US FDA Commissioner Nominee Hahn On Fast Track With 20 November Hearing
Executive Summary
Stephen Hahn will go before the Senate health committee less than three weeks after being nominated. Pink Sheet's historical charts illustrate how a long wait and a quick hearing could mean a rapid confirmation.
You may also be interested in...
No Shutdown But Funding Lower Than House Bill In US FDA Budget Forecast
Former Senate Appropriations Committee staffer expects FDA's FY 2020 budget will not be finalized until early next year and that it will be close to the sum in the appropriations bill passed by the Senate.
Hahn May Not Run Into Questions About Industry Ties Like His Predecessors
Nominee for US FDA commissioner has remained largely focused on academic work and private practice, receiving only a few payments from pharma and device companies.
Stephen Hahn For US FDA Commissioner: Will Academic Experience Suffice For Confirmation?
The MD Anderson Cancer Center administrator's lack of significant government administration experience may inspire questions during the confirmation process.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to HBW Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: